2023-2029 Global Recombinant Antibody Production Service Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Recombinant Antibody Production Service Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Recombinant Antibody Production Service Market Restraints
Table 3. Recombinant Antibody Production Service Market Trends
Table 4. Recombinant Antibody Production Service Industry Policy
Table 5. Global Recombinant Antibody Production Service Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Recombinant Antibody Production Service Revenue Market Share by Company (2018-2023)
Table 7. Global Recombinant Antibody Production Service Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Recombinant Antibody Production Service Mergers & Acquisitions, Expansion Plans
Table 9. Global Recombinant Antibody Production Service Manufacturers Product Type
Table 10. China Recombinant Antibody Production Service Revenue by Company (2018-2023) & (US$ million)
Table 11. China Recombinant Antibody Production Service Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Recombinant Antibody Production Service Upstream (Raw Materials)
Table 13. Global Recombinant Antibody Production Service Typical Customers
Table 14. Recombinant Antibody Production Service Typical Distributors
Table 15. By Type, Global Recombinant Antibody Production Service Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Recombinant Antibody Production Service Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Recombinant Antibody Production Service Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Recombinant Antibody Production Service Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Recombinant Antibody Production Service Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Recombinant Antibody Production Service Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Recombinant Antibody Production Service Revenue Market Share, 2018-2029
Table 22. evitria SA Company Information, Head Office, Market Area and Industry Position
Table 23. evitria SA Company Profile and Main Business
Table 24. evitria SA Recombinant Antibody Production Service Models, Specifications and Application
Table 25. evitria SA Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 26. evitria SA Recent Developments
Table 27. Bon Opus Biosciences Company Information, Head Office, Market Area and Industry Position
Table 28. Bon Opus Biosciences Company Profile and Main Business
Table 29. Bon Opus Biosciences Recombinant Antibody Production Service Models, Specifications and Application
Table 30. Bon Opus Biosciences Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 31. Bon Opus Biosciences Recent Developments
Table 32. Biomatik Company Information, Head Office, Market Area and Industry Position
Table 33. Biomatik Company Profile and Main Business
Table 34. Biomatik Recombinant Antibody Production Service Models, Specifications and Application
Table 35. Biomatik Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 36. Biomatik Recent Developments
Table 37. Biointron Biological Inc. Company Information, Head Office, Market Area and Industry Position
Table 38. Biointron Biological Inc. Company Profile and Main Business
Table 39. Biointron Biological Inc. Recombinant Antibody Production Service Models, Specifications and Application
Table 40. Biointron Biological Inc. Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 41. Biointron Biological Inc. Recent Developments
Table 42. Sino Biological Company Information, Head Office, Market Area and Industry Position
Table 43. Sino Biological Company Profile and Main Business
Table 44. Sino Biological Recombinant Antibody Production Service Models, Specifications and Application
Table 45. Sino Biological Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 46. Sino Biological Recent Developments
Table 47. ProSci Inc Company Information, Head Office, Market Area and Industry Position
Table 48. ProSci Inc Company Profile and Main Business
Table 49. ProSci Inc Recombinant Antibody Production Service Models, Specifications and Application
Table 50. ProSci Inc Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 51. ProSci Inc Recent Developments
Table 52. GenScript Company Information, Head Office, Market Area and Industry Position
Table 53. GenScript Company Profile and Main Business
Table 54. GenScript Recombinant Antibody Production Service Models, Specifications and Application
Table 55. GenScript Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 56. GenScript Recent Developments
Table 57. RayBiotech Company Information, Head Office, Market Area and Industry Position
Table 58. RayBiotech Company Profile and Main Business
Table 59. RayBiotech Recombinant Antibody Production Service Models, Specifications and Application
Table 60. RayBiotech Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 61. RayBiotech Recent Developments
Table 62. Cygnus Technologies Company Information, Head Office, Market Area and Industry Position
Table 63. Cygnus Technologies Company Profile and Main Business
Table 64. Cygnus Technologies Recombinant Antibody Production Service Models, Specifications and Application
Table 65. Cygnus Technologies Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 66. Cygnus Technologies Recent Developments
Table 67. Cusabio Technology Company Information, Head Office, Market Area and Industry Position
Table 68. Cusabio Technology Company Profile and Main Business
Table 69. Cusabio Technology Recombinant Antibody Production Service Models, Specifications and Application
Table 70. Cusabio Technology Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 71. Cusabio Technology Recent Developments
Table 72. Absolute Antibody Company Information, Head Office, Market Area and Industry Position
Table 73. Absolute Antibody Company Profile and Main Business
Table 74. Absolute Antibody Recombinant Antibody Production Service Models, Specifications and Application
Table 75. Absolute Antibody Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 76. Absolute Antibody Recent Developments
Table 77. Cayman Chemical Company Information, Head Office, Market Area and Industry Position
Table 78. Cayman Chemical Company Profile and Main Business
Table 79. Cayman Chemical Recombinant Antibody Production Service Models, Specifications and Application
Table 80. Cayman Chemical Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 81. Cayman Chemical Recent Developments
Table 82. Creative Biolabs Company Information, Head Office, Market Area and Industry Position
Table 83. Creative Biolabs Company Profile and Main Business
Table 84. Creative Biolabs Recombinant Antibody Production Service Models, Specifications and Application
Table 85. Creative Biolabs Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 86. Creative Biolabs Recent Developments
Table 87. Promab Biotechnologies Company Information, Head Office, Market Area and Industry Position
Table 88. Promab Biotechnologies Company Profile and Main Business
Table 89. Promab Biotechnologies Recombinant Antibody Production Service Models, Specifications and Application
Table 90. Promab Biotechnologies Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 91. Promab Biotechnologies Recent Developments
Table 92. Leinco Technologies Company Information, Head Office, Market Area and Industry Position
Table 93. Leinco Technologies Company Profile and Main Business
Table 94. Leinco Technologies Recombinant Antibody Production Service Models, Specifications and Application
Table 95. Leinco Technologies Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 96. Leinco Technologies Recent Developments
Table 97. R&D Systems Company Information, Head Office, Market Area and Industry Position
Table 98. R&D Systems Company Profile and Main Business
Table 99. R&D Systems Recombinant Antibody Production Service Models, Specifications and Application
Table 100. R&D Systems Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 101. R&D Systems Recent Developments
Table 102. Rapid Novor Company Information, Head Office, Market Area and Industry Position
Table 103. Rapid Novor Company Profile and Main Business
Table 104. Rapid Novor Recombinant Antibody Production Service Models, Specifications and Application
Table 105. Rapid Novor Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 106. Rapid Novor Recent Developments
Table 107. ACROBiosystems Company Information, Head Office, Market Area and Industry Position
Table 108. ACROBiosystems Company Profile and Main Business
Table 109. ACROBiosystems Recombinant Antibody Production Service Models, Specifications and Application
Table 110. ACROBiosystems Recombinant Antibody Production Service Revenue and Gross Margin, 2018-2023
Table 111. ACROBiosystems Recent Developments
List of Figure
Figure 1. Recombinant Antibody Production Service Picture
Figure 2. Global Recombinant Antibody Production Service Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Recombinant Antibody Production Service Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Recombinant Antibody Production Service Market Share of Global
Figure 5. Global Recombinant Antibody Production Service Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Recombinant Antibody Production Service Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Recombinant Antibody Production Service Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Recombinant Antibody Production Service Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Recombinant Antibody Production Service Industry Chain
Figure 10. High-throughput Antibody Production Service
Figure 11. Small to Mid-scale Antibody Production Service
Figure 12. Large-scale Antibody Production Service
Figure 13. Chimeric Antibody Production Service
Figure 14. Antibody Fragment Production Service
Figure 15. Bispecific Antibody Production Service
Figure 16. Others
Figure 17. By Type, Global Recombinant Antibody Production Service Revenue, 2018-2029, US$ Million
Figure 18. By Type, Global Recombinant Antibody Production Service Revenue Market Share, 2018-2029
Figure 19. Pharmaceutical
Figure 20. Biotechnology Company
Figure 21. Others
Figure 22. By Application, Global Recombinant Antibody Production Service Revenue, 2018-2029, US$ Million
Figure 23. By Application, Global Recombinant Antibody Production Service Revenue Market Share, 2018-2029
Figure 24. By Region, Global Recombinant Antibody Production Service Revenue Market Share, 2018-2029
Figure 25. North America Recombinant Antibody Production Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, North America Recombinant Antibody Production Service Revenue Market Share, 2018-2023
Figure 27. Europe Recombinant Antibody Production Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, Europe Recombinant Antibody Production Service Revenue Market Share, 2018-2023
Figure 29. Asia Pacific Recombinant Antibody Production Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country/Region, Asia Pacific Recombinant Antibody Production Service Revenue Market Share, 2018-2023
Figure 31. South America Recombinant Antibody Production Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. By Country, South America Recombinant Antibody Production Service Revenue Market Share, 2018-2023
Figure 33. Middle East & Africa Recombinant Antibody Production Service Revenue & Forecasts, 2018-2029, US$ Million
Figure 34. U.S. Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, U.S. Recombinant Antibody Production Service Market Share, 2018-2023
Figure 36. By Type, U.S. Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 37. By Application, U.S. Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 38. Europe Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, Europe Recombinant Antibody Production Service Market Share, 2018-2023
Figure 40. By Type, Europe Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 41. By Application, Europe Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 42. China Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, China Recombinant Antibody Production Service Market Share, 2018-2023
Figure 44. By Type, China Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 45. By Application, China Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 46. Japan Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, Japan Recombinant Antibody Production Service Market Share, 2018-2023
Figure 48. By Type, Japan Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 49. By Application, Japan Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 50. South Korea Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, South Korea Recombinant Antibody Production Service Market Share, 2018-2023
Figure 52. By Type, South Korea Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 53. By Application, South Korea Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 54. Southeast Asia Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, Southeast Asia Recombinant Antibody Production Service Market Share, 2018-2023
Figure 56. By Type, Southeast Asia Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 57. By Application, Southeast Asia Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 58. India Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, India Recombinant Antibody Production Service Market Share, 2018-2023
Figure 60. By Type, India Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 61. By Application, India Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 62. Middle East & Asia Recombinant Antibody Production Service Revenue, 2018-2029, (US$ Million)
Figure 63. By Company, Middle East & Asia Recombinant Antibody Production Service Market Share, 2018-2023
Figure 64. By Type, Middle East & Asia Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 65. By Application, Middle East & Asia Recombinant Antibody Production Service Revenue Market Share, 2022 VS 2029
Figure 66. Research Methodology
Figure 67. Breakdown of Primary Interviews
Figure 68. Bottom-up Approaches
Figure 69. Top-down Approaches

Reason to Buy

• Current and future of Service & Software Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Service & Software Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets